Dr. Reddy’s Laboratories rises on launching Olanzapine tablets

25 Apr 2012 Evaluate

Dr. Reddy’s Laboratories is currently trading at Rs. 1780.50, up by 13.70 points or 0.78% from its previous closing of Rs. 1766.80 on the BSE.

The scrip opened at Rs. 1778.00 and has touched a high and low of Rs. 1785.05 and Rs. 1775.00 respectively.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1818.00 on 20-Apr-2012 and a 52 week low of Rs. 1387.00 on 22-Aug-2011.

Last one week high and low of the scrip stood at Rs. 1818.00 and Rs. 1755.00 respectively. The current market cap of the company is Rs. 30,177.00 crore.

The promoters holding in the company stood at 25.61% while Institutions and Non-Institutions held 40.85% and 16.73% respectively.

Dr. Reddy’s Laboratories has launched Olanzapine tablets (2.5mg, 5mg, 7.5mg, 10mg, 15mg), a bioequivalent generic version of ZYPREXA tablets in the US market on April 23, 2012 following the approval by the United States Food & Drug Administration (USFDA) of the company's ANDA for Olanzapine tablets.

Dr. Reddy’s Olanzapine tablets in 20 mg had been awarded a 180-day period of marketing exclusivity in the US on October 26, 2011 which was commercialized through a commercial, manufacture and supply agreement with Teva Pharmaceutical Industries.

The ZYPREXA tablets brand and generic had combined US sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Olanzapine tablets in 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20mg strengths are available in 30 and 500 count bottles.

Dr. Reddys Lab Share Price

1271.05 5.10 (0.40%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×